BABA vs MCFT

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

MCFT exhibits strong operational health with a Piotroski F-Score of 7/9 and a healthy current ratio of 2.07, though an Altman Z-Score was not provided. While the company consistently delivers massive earnings surprises and outperforms sector profitability averages, the stock is trading at a significant premium to its Graham Number ($15.67) and Intrinsic Value ($6.58). This valuation gap, combined with bearish insider selling and a 0/100 technical trend, offsets the positive fundamental momentum. The outlook is neutral as the market prices in high growth expectations that exceed current deterministic value baselines.